NeuralScan System— 510(k) K192753

Substantially Equivalent

Medeia, Inc.

FDA 510(k) clearance K192753 for NeuralScan System, Substantially Equivalent on 2020-03-17. Applicant: Medeia, Inc.. Device class: 2.

Clearance details

Applicant: Medeia, Inc.
Product code: Code GWQ
Device class: Class 2
Regulation: 21 CFR 882.1400
Advisory panel: Neurology
Date received: 2019-09-30
Decision date: 2020-03-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Barbara, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GWQ

K261604 — Enobio Dx (3 models)2026-06-13
K260455 — New Wave System2026-03-13
K233403 — Flexset System2024-04-30
K231366 — Neuronaute Plus2023-11-09
K221959 — Q212023-08-31

More clearances from Medeia, Inc.

K212684 — BrainView QEEG Software2023-01-28
K191266 — VitalScan ANS2020-01-15
K150804 — QBioScan2015-10-19

Data sourced from openFDA. This site is unofficial and independent of the FDA.